Newsroom

Thursday, Nov 3, 2011

• Adamis Prostate Cancer Drug APC-100 Receives Allowance for Patent in CanadaBusiness Wire

Tuesday, Oct 25, 2011

• Crystal Research Report on Adamis Pharmaceuticals

Tuesday, Oct 4, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online

Thursday, Sep 22, 2011

• Adamis Prostate Cancer Drug APC-200 Granted Patents in Singapore and South AfricaBusiness Wire

Friday, Sep 16, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online

Tuesday, Aug 30, 2011

• Adamis Pharmaceuticals Begins Prostate Cancer TrialBusiness Wire

Monday, Aug 15, 2011

• ADAMIS PHARMACEUTICALS CORP FinancialsEDGAR Online Financials

Thursday, Jul 28, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other EventsEDGAR Online

Thursday, Jul 21, 2011

• Adamis Prostate Cancer Drug APC-100 Granted a Patent in USBusiness Wire

Wednesday, Jul 20, 2011

• Adamis Reports APC-300 Kills Human Prostate Cancer CellsBusiness Wire

Wednesday, Jul 13, 2011

• Adamis Vaccine Technology Granted a Patent in EuropeBusiness Wire

Tuesday, Jul 12, 2011

• ADAMIS PHARMACEUTICALS CORP FinancialsEDGAR Online Financials(Tue, Jul 12)

Thursday, Jul 7, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other EventsEDGAR Online(Thu, Jul 7)

Thursday, Jun 9, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, Jun 9)

Wednesday, June 8, 2011

• FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer
  Business Wire 

Wednesday, April 27

• UCSD, Harvard license cancer vaccine technology to Adamis Pharmaceuticals

Tuesday, April 19

• Adamis Completes Acquisition of a Technology for a Potential Universal Cancer Vaccine

Thursday, March 24, 2011

• Adamis Reports APC-300 Kills Human Pancreatic Cancer CellsBusiness Wire (Thu, Mar 24)

Wednesday, March 9, 2011

• Adamis Pharmaceuticals Files IND for Product Candidate to Treat Prostate CancerBusiness Wire (Wed, Mar 9)

Wednesday, February 16, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online (Wed, Feb 16)
• Adamis Pharmaceuticals Announces Appointment of New Additional DirectorsBusiness Wire (Wed, Feb 16)

Tuesday, February 15, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Feb 15)

Thursday, January 13, 2011

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online (Thu, Jan 13)
• Adamis Pharmaceuticals Announces Appointment of New Additional DirectorsMarketwire (Thu, Jan 13)

• ADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim ReviewEDGAR Online (Tue, Jul 20)

more news